🇺🇸 FDA
Pipeline program

PV-10

PV-10-MM-1201

Phase 2 small_molecule active

Quick answer

PV-10 for Melanoma is a Phase 2 program (small_molecule) at PROVECTUS BIOPHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
PROVECTUS BIOPHARMACEUTICALS, INC.
Indication
Melanoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials